We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Nmc Health Plc | LSE:NMC | London | Ordinary Share | GB00B7FC0762 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 938.40 | 940.00 | 941.60 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMNMC
RNS Number : 1620R
NMC Health Plc
12 June 2018
NMC Health plc
Exercise of share options
London, 12(th) June 2018: NMC Health Plc ("NMC" or the "Company") (LSE:NMC), the leading United Arab Emirates private healthcare operator with international services across 13 countries, announces that on 11 June 2018 the following individuals exercised nil-cost share options granted to them in 2017 under the Company's Deferred Share Bonus Plan ("DSBP").
Following the exercise of these options, the Company issued new Ordinary shares of 10p each respectively to each individual as follows:
Name of individual Director/PDMR Incentive Number Plan of shares allotted -------------------- --------------- ------------ ----------- Dr B. R. Shetty Director DSBP 19,884 -------------------- --------------- ------------ ----------- Dr C. R. Shetty PDMR DSBP 11,012 -------------------- --------------- ------------ ----------- Total 30,896 --------------------------------------------------- -----------
This notification is made in accordance with the Market Abuse Regulation.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1 Details of the person discharging managerial responsibilities / person closely associated --- ---------------------------------------------------- a) Name Dr B. R. Shetty Dr C. R. Shetty --- ----------------- --------------------------------- 2 Reason for the notification --- ---------------------------------------------------- a) Position/status Director and PDMR of the Company --- ----------------- --------------------------------- b) Initial Initial notification notification /Amendment --- ----------------- --------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ---------------------------------------------------- a) Name NMC Health plc --- ----------------- --------------------------------- b) LEI 2138008YQEVWBE1V2M52 --- ----------------- --------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ---------------------------------------------------- a) Description Options over Ordinary Shares of the financial instrument, ISIN: GB00B7FC0762 type of instrument Identification code --- ----------------- --------------------------------- b) Nature Exercise of nil-cost options of the transaction --- ----------------- --------------------------------- c) Price(s) Price No. of shares and volume(s) for above individuals respectively ------ -------------- 0p 19,884 ------ -------------- 0p 11,012 ------ -------------- --- ----------------- --------------------------------- d) Aggregated N/A information - volume - Price - Total --- ----------------- --------------------------------- e) Date of 11 June 2018 the transaction --- ----------------- --------------------------------- f) Place of Not on a trading venue the transaction --- ----------------- ---------------------------------
Contacts
NMC Simon Watkins Group Company Secretary +44 (0)20 3205 7313 Media FTI Consulting, London Brett Pollard +44 (0)20 3727 1000 FTI Consulting, Gulf Shane Dolan +971 (0)4 437 2100
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHEALKAFDAPEFF
(END) Dow Jones Newswires
June 12, 2018 10:35 ET (14:35 GMT)
1 Year Nmc Health Chart |
1 Month Nmc Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions